DR. THOMAS WALKER ROBINSON, M.D., M.P.H.
Medical Practice at Sage Rd, Chapel Hill, NC
License number
North Carolina 2013-01239
Category
Medical Practice
Type
Pediatrics
Address
Address
2
205 Sage Rd SUITE 100, Chapel Hill, NC 27514
928 Clarion Dr, Durham, NC 27705
928 Clarion Dr, Durham, NC 27705
Phone
(919) 942-4173
(919) 452-5412
(919) 452-5412
Personal information
See more information about THOMAS WALKER ROBINSON at radaris.comName
Address
Phone
512 Beaver Dam Run, Durham, NC 27703
513 Moir St, Eden, NC 27288
5129 Dallas High Shoals Hwy, Dallas, NC 28034
508 Covington Ridge Rd, Winston Salem, NC 27107
506 Franklin St, Mount Olive, NC 28365
Professional information
Thomas Robinson
Work:
NCCU James E. Shepard Memorial Library - Durham, NC
Serials Assistant (University Work Aid The George Watts Hill Center - Durham, NC
Tutor Durham Public Schools - Durham, NC
Substitute Teacher K-12 North Carolina Central University - Durham, NC
Graduate Assistant Project Vote Smart - Philipsburg, MT
National Intern
Serials Assistant (University Work Aid The George Watts Hill Center - Durham, NC
Tutor Durham Public Schools - Durham, NC
Substitute Teacher K-12 North Carolina Central University - Durham, NC
Graduate Assistant Project Vote Smart - Philipsburg, MT
National Intern
Education:
North Carolina Central University - Durham, NC
Master of Arts in History Saint Augustine's University - Raleigh, NC
Bachelor of Arts in History
Master of Arts in History Saint Augustine's University - Raleigh, NC
Bachelor of Arts in History
Dr. Thomas W Robinson, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Age:
45
Address:
Chapel Hill Pediatrics/Adlscnts
205 Sage Rd SUITE 100, Chapel Hill 27514
(919) 942-4173 (Phone)
205 Sage Rd SUITE 100, Chapel Hill 27514
(919) 942-4173 (Phone)
Certifications:
Obstetrics & Gynecology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Duke University
Graduated: 2009
University of Virginia / Main Campus
Graduated: 1993
U Tex Med Br
Duke University
Graduated: 2009
University of Virginia / Main Campus
Graduated: 1993
U Tex Med Br
Chalcone And Its Analogs As Agents For The Inhibition Of Angiogensis And Related Disease States
US Patent:
6462075, Oct 8, 2002
Filed:
Dec 26, 2000
Appl. No.:
09/748599
Inventors:
J. Phillip Bowen - Hull GA
Thomas Phillip Robinson - Durham NC
Tedman Ehlers - Athens GA
David Goldsmith - Atlanta GA
Jack Arbiser - Atlanta GA
Thomas Phillip Robinson - Durham NC
Tedman Ehlers - Athens GA
David Goldsmith - Atlanta GA
Jack Arbiser - Atlanta GA
Assignee:
The University of Georgia Research Foundation, Inc. - Athens GA
Emory University - Atlanta GA
Emory University - Atlanta GA
International Classification:
C07D31100
US Classification:
514460, 514685, 514729, 549401, 568326, 568334
Abstract:
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, incluidng angiongenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.
Thomas Walker Robinson, Chapel Hill NC
Specialties:
Pediatrician
Address:
205 Sage Rd, Chapel Hill, NC 27514
Chalcone And Its Analogs As Agents For The Inhibition Of Angiogenesis And Related Disease States
US Patent:
7432303, Oct 7, 2008
Filed:
Mar 8, 2005
Appl. No.:
11/074545
Inventors:
J. Phillip Bowen - Hull GA, US
Thomas Philip Robinson - Durham NC, US
Tedman Ehlers - Athens GA, US
David Goldsmith - Atlanta GA, US
Jack Arbiser - Atlanta GA, US
Thomas Philip Robinson - Durham NC, US
Tedman Ehlers - Athens GA, US
David Goldsmith - Atlanta GA, US
Jack Arbiser - Atlanta GA, US
Assignee:
James and Emory University - Atlanta GA
International Classification:
C07C 49/11, C07C 49/115, A61K 31/12
US Classification:
514679, 514680, 568325, 568326
Abstract:
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, including angiongenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.
Chalcone And Its Analogs As Agents For The Inhibition Of Angiogenesis And Related Disease States
US Patent:
7872029, Jan 18, 2011
Filed:
Aug 22, 2008
Appl. No.:
12/229340
Inventors:
J. Phillip Bowen - Hull GA, US
Thomas Philip Robinson - Durham NC, US
Tedman Ehlers - Athens GA, US
David Goldsmith - Atlanta GA, US
Jack Arbiser - Atlanta GA, US
Thomas Philip Robinson - Durham NC, US
Tedman Ehlers - Athens GA, US
David Goldsmith - Atlanta GA, US
Jack Arbiser - Atlanta GA, US
International Classification:
C07D 213/02, A61K 31/44
US Classification:
514332, 514354, 514685, 546262, 546340, 568334
Abstract:
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, including angiogenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.
Chalcone And Its Analogs As Agents For The Inhibition Of Angiogenesis And Related Disease States
US Patent:
6906105, Jun 14, 2005
Filed:
Jul 18, 2002
Appl. No.:
10/198786
Inventors:
J. Phillip Bowen - Hull GA, US
Thomas Philip Robinson - Durham NC, US
Tedman Ehlers - Athens GA, US
David Goldsmith - Atlanta GA, US
Jack Arbiser - Atlanta GA, US
Thomas Philip Robinson - Durham NC, US
Tedman Ehlers - Athens GA, US
David Goldsmith - Atlanta GA, US
Jack Arbiser - Atlanta GA, US
International Classification:
A61K031/12, C07C049/213
US Classification:
514679, 568325
Abstract:
The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, including angiongenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.